期刊文献+

CTRP9与2型糖尿病相关动脉粥样硬化的研究进展 被引量:1

Research progress of CTRP9 and type 2 diabetes mellitus associated with atherosclerosis
原文传递
导出
摘要 冠心病是2型糖尿病的主要并发症,也是2型糖尿病患者死亡的重要原因,延缓2型糖尿病患者动脉粥样硬化的进展成为提高人类生活质量的紧迫问题。C1q肿瘤坏死因子相关蛋白9(CTRP9)作为心血管保护因子,在延缓2型糖尿病相关动脉粥样硬化的进展中发挥什么作用,是目前学术界研究的热点。本综述总结了CTRP9在2型糖尿病相关动脉粥样硬化中作用的最新进展,重点介绍其在2型糖尿病相关动脉粥样硬中的作用机制,为预防及治疗糖尿病相关动脉粥样硬化提供新的思路及解决方法。 Coronary atherosclerotic heart disease is not only a major complication of type 2 diabetes mellitus but also an important cause of death in patients with this condition.Delaying the progress of atherosclerosis in patients with type 2 diabetes mellitus has become an urgent issue to improve human life quality.Accumulated evidence suggests that C1 q tumor necrosis factor-related protein 9(CTRP9)could play a role in preventing the progression of type 2 diabetes-related atherosclerosis.In this review,we summarize the latest progress in the role of CTRP9 in type 2 diabetes-related atherosclerosis,focusing on its mechanism in type 2 diabetes-related atherosclerosis to provide new ideas and solutions for the prevention and treatment of diabetes-related atherosclerosis.
作者 马雅楠 金晓雪 刘德敏 谷国强 MA Ya'nan;JIN Xiaoxue;LIU Demin;GU Guoqiang(Department of Cardiology,The Second Hospital of Hebei Medical University.Shijiazhuang,050000,China)
出处 《临床心血管病杂志》 CAS 北大核心 2022年第10期833-837,共5页 Journal of Clinical Cardiology
基金 河北省自然科学基金精准医学联合基金重点项目(No:H2020206409) 河北省自然科学基金资助项目(No:H2021206220)。
关键词 CTRP9 2型糖尿病 动脉粥样硬化 CTRP9 type 2 diabetes mellitus atherosclerosis
  • 相关文献

参考文献3

二级参考文献50

  • 1WU A H. The ischemia-modified albumin biomarker for myocardial ischemia[J]. MLO Med Lab Obs, 2003,35.. 36-38,40. 被引量:1
  • 2CHARO I F, RANSOHOFF R M. The many roles of chemokines and chemokine receptors in inflammation[J].NEnglJ Med,2006,354:610--621. 被引量:1
  • 3VIOLA A, LUSTER A D. Chemokines and their receptors : drug targets in immunity and inflammation[J]. Annu Rev Pharmacol Toxicol ,2008,48:171-197. 被引量:1
  • 4LIBBY P. Inflammation in atherosclerosis[J]. Nature, 2002,420:868-874. 被引量:1
  • 5CROCE K, LIBBY P. Intertwining of thrombosis and inflammation in atherosclerosis[J]. Curr Opin Hematol,2007,14:55-61. 被引量:1
  • 6STRUKOVA S. Blood coagulation-dependent inflam- mation. Coagulation-dependent inflammation and in- flammation-dependent thrombosis[J]. Front Biosci, 2006,11 :59-80. 被引量:1
  • 7LEVI M, VAN DER POLL T, TEN CATE H. Tissue factor in infection and severe inflammation[J]. Semin Thromb Hemost, 2006,32 : 33 - 39. 被引量:1
  • 8VIEDT C, VOGEL J, ATHANASIOU T, et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1[J].Arterioscler Thromb Vasc Biol, 2002, 22:914-920. 被引量:1
  • 9WERLE M, SCHMAL U, HANNA K, et al. MCP- 1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells[J]. Cardiovasc Res, 2002,56 : 284-292. 被引量:1
  • 10MUKAIDA N, HARADA A, MATSUSHIMA K. Interleukin-8 (IL- 8) and monocyte chemotactic and activating factor (MCAF/MCP-1) chemokines essentially involved in inflammatory and immune reactions [J]. Cytokine Growth Factor Rev, 1998,9:9-23. 被引量:1

共引文献29

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部